| Status | Study |
| Recruiting |
Study Name: Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA Condition: Myelodysplastic Syndrome MDS Refract Date: 2015-09-25 Interventions: Drug: rigosertib Patients will |
| Recruiting |
Study Name: Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome Condition: Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Date: 2015-07-27 Interventions: Drug: Azacitidine Given intrav |
| Active, not recruiting |
Study Name: Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine Condition: Myelodysplastic Syndromes Refractory Anemia With Excess Blasts Date: 2013-08-21 Interventions: Drug: rigosertib sodium Other Names: ON 01910.Na SyB L-1101 |
| Active, not recruiting |
Study Name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Date: 2013-04-12 Interventions: Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401 |
| Recruiting |
Study Name: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2013-01-02 Interventions: Drug: Fludarabine phosphate Gi |
| Terminated |
Study Name: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler Condition: Acute Myeloid Leukemia (AML) Acute Promyelocytic Leukemia (APL) Date: 2011-10-28 |
| Completed |
Study Name: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies Condition: Acute Lymphoid Leukemia Acute Myeloid Leukemia Date: 2011-10-24 Interventions: Drug: brentuximab vedotin 1.8 |
| Completed |
Study Name: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission Date: 2010-08-03 Interventions: Procedure: umbilical cord blood transplantation |
| Completed |
Study Name: Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Date: 2010-06-16 Interventions: Other: laboratory biomarker analysis Correlative studies |
| Terminated |
Study Name: Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation Condition: Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Mye Date: 2008-12-15 Interventions: Biological: GM-K562/leukemia cell vaccine Cultured cell line genetically changed to secrete GM-CSF mixed |